Skip to main content
 
 

Personal Investment Advice

Achieve your investment goals with personalised advice and a comprehensive range of wealth management services.

Learn more
 
 

Corporate Advisory Services

Our corporate advisory services aims to provide value creating client-focused advice and execution for emerging companies.

Learn more
 
 

Institutional Investor Services

Our institutional investor services team deliver innovative solutions for institutions backed by global resources and expertise.

Learn more

At Bell Potter, we bring together people, ideas and capital to serve the needs of our clients.

HOW CAN WE HELP YOU?

As a leading full service Australian stockbroking and financial advisory firm, we provide a comprehensive range of services for our clients.

Personal

  • Australian Stockbroking
  • International Stockbroking
  • Fixed Income
  • Portfolio Administration
  • Technical Financial Advice
  • Superannuation
  • Foreign Exchange
  • Lending
  • At-Call Facilities

Go to section

Corporates

  • Placements
  • Market sell-downs & block trades
  • Equity Capital raisings
  • IPOs
  • Corporate Advice & Structuring
  • Share Price Advice & Valuation
  • Mergers & Acquisition Advice & Execution

Go to section

Institutions

  • Sales
  • Trading
  • Research
  • Corporate Access

Go to section

Research

  • Equities
  • Strategy
  • Hybrid & Fixed income
  • LICs & ETFs
  • Currency
  • Commodities

Go to section

Advisers

  • General advice
  • Execution, Clearing & Settlement
  • Stock market advisory services
  • Research
  • Corporate opportunities
  • mFunds

Go to section

Quality advice starts with a conversation

Speak with an experienced adviser today.

REQUEST A CALLBACK

IDEAS AND RESEARCH

Harvey Norman (HVN): Moving the dial

| Equities, Retail | No Comments
Harvey Norman’s 1H25 results exceeded expectations, with a 3% price target increase to $6.00, and maintaining a Buy recommendation.

IVE Group (IGL): Guidance looks conservative

| Equities, Technology | No Comments
IVE Group beat 1HFY25 expectations, raised its FY25 NPAT guidance, and increased its price target to $2.80, maintaining a Buy rating.

Pro Medicus (PME): Growth rate accelerating

| Equities, Healthcare & Biotech | No Comments
PME’s growth in core radiology and cardiology services supports an upgraded Buy rating with a price target of $330.
MORE IDEAS

ABOUT US

Bell Potter is a member of the Bell Financial Group (BFG.ASX) of companies. We are one of Australia’s leading full service Australian stockbroking and financial advisory firms, offering a full range of services to private, corporate and institutional clients.

Find out more